In a recent article published by ‘Manufacturing Chemist‘, our CEO, Dr. Yuchen Zhou, provides a comprehensive insight into the obstacles impacting stem cell therapy research. A significant issue lies in the cell separation stage, often leading to lengthy preparation times and substantial cell loss.
Dr. Zhou articulates the ambition of Applied Cells Inc.: to address these hurdles through advanced cell separation technology. Central to this mission is our innovative MARS® technology. With its distinctive in-flow method, MARS® is setting a new standard, removing the need for conventional separation columns and traditional processes like gradient centrifugation.
Discover more: Overcoming cell separation challenges to advance stem cell therapy research.
Kat Ginda-Mäkelä
info@appliedcells.com
